Related Experiment Videos
[A role of inhaled disodium cromoglycate in child asthma]
1Department of Respiratory, National Kagawa Children's Hospital.
Insights
Disodium clomoglycate (DSCG) is a primary treatment for childhood asthma in Japan. Future treatments may combine DSCG with beclomethasone dipropionate (BDP) for improved asthma management.
Area of Science:
- Pediatric Pulmonology
- Pharmacology
Abstract:
Inhalation of disodium clomoglycate (DSCG) is main therapy for childhood asthma in Japan. Regular inhalation of both DSCG and beta 2 stimulant is recommended for the treatment of severe asthma in the guideline which was made in 1993. Characteristic of childhood asthma such as retardation of growth and exercise-induced asthma is considered as an important view point in Japanese pediatric field. On the other hand inhalation of beclomethasone dipropionate (BDP) is used for the treatment of adult-hood asthma in Japan and WHO global storategy. In the future new treatment will be developed using both DSCG and BDP.